Pharmacokinetics of switching unboosted atazanavir coadministered with tenofovir disoproxil fumarate from 400 mg once daily to 200 mg twice daily in HIV-positive patients

Stefano BONORA, Daniel GONZALEZ DE REQUENA, ANTONIO D'AVOLIO, Andrea CALCAGNO, M Tettoni, MARCO SICCARDI, LORENA BAIETTO, MARCO SIMIELE, L Trentini, Giovanni DI PERRI

Risultato della ricerca: Contributo su rivistaArticolo in rivistapeer review

Lingua originaleInglese
pagine (da-a)499-504
Numero di pagine6
RivistaAntiviral Therapy
Volume16
DOI
Stato di pubblicazionePubblicato - 2011

Keywords

  • Adenine
  • administration /&/ dosage/analogs /&/ derivatives/pharmacokinetics
  • Adult
  • Anti-HIV Agents
  • administration /&/ dosage/pharmacokinetics/therapeutic use
  • Deoxycytidine
  • Drug Administration Schedule
  • Drug Therapy
  • Combination
  • HIV Seropositivity
  • drug therapy
  • HIV-1
  • drug effects
  • Humans
  • Male
  • Middle Aged
  • Oligopeptides
  • administration /&/ dosage/pharmacokinetics
  • Phosphonic Acids
  • Pyridines
  • Reverse Transcriptase Inhibitors
  • Treatment Outcome

Cita questo